• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS KONECT RESILIA AORTIC VALVED CONDUIT; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS KONECT RESILIA AORTIC VALVED CONDUIT; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11060A
Device Problem Nonstandard Device (1420)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/22/2022
Event Type  Injury  
Manufacturer Narrative
The gelweave valsalva graft is made of woven polyester, which has been impregnated with gelatin.The gelatin serves in place of fibrin, which seals the polyester prosthesis during normal pre-clotting.If excess gelatin mass were to accumulate inside the graft, this could lead to embolization, resulting in a partial or total blockage of blood flow in an affected vessel.The severity of harm would depend upon the location of the emboli.Cerebral arteries were involved, stroke may occur or peripheral embolism to a 3-5mm blood vessel.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.
 
Event Description
It was reported that a 29mm valved conduit had gel-like debris inside the graft after implant.Per rep the graft immersed in saline for 5 minutes.The graft did not dry out after immersing in saline prior to implant.The debris was seen by surgeon and removed using a sucker.The product was in the rep's inventory and kept in proper conditions.The surgical team could clearly scrape the debris off and were using the sucker tip to remove anything they could see.It was noticed on both parts of the graft.Per medical records the patient presented with ascending aortic aneurysm, aortic insufficiency, and underwent bentall procedure.The echo reviewed valve working normally.The patient was discharged home in good condition on pod #4.
 
Manufacturer Narrative
Based on the information available, the complaint of gel-like debris is confirmed by product evaluation, however, a manufacturing non-conformance could not be confirmed as the returned fragment would have passed visual inspections during manufacturing.The device history record (dhr) was reviewed and showed that this device met all manufacturing and sterilization specifications for product release prior to distribution.No issues were identified that would have impacted this event.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Manufacturer Narrative
Customer report of gel-like debris was confirmed.Returned valsalva graft fragment had traces of blood residue and was approximately 5cm long in its as received un-stretched state.A clear, gel-like particulate approximately 3mm long was observed on the outer folds of the graft.No other visible inconsistencies were observed from returned graft.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS KONECT RESILIA AORTIC VALVED CONDUIT
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer Contact
reginald santos
one edwards way
mailstop anton 6.1
irvine, CA 92614
9492502731
MDR Report Key15003324
MDR Text Key295808847
Report Number2015691-2022-06751
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00690103201406
UDI-Public(01)00690103201406(17)231013
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 09/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/13/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number11060A
Device Catalogue Number11060A29
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received09/16/2022
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age40 YR
-
-